Imperial College Healthcare NHS Trust (ICHT)

Imperial College Healthcare NHS Trust provides acute and specialist health care in north west London for around a million and a half people every year. Formed in 2007, we are one of the largest NHS trusts in the country, with more than 11,500 staff and turnover of £1,126 million.

Our hospitals

Our five hospitals – Charing Cross, Hammersmith, Queen Charlotte’s & Chelsea, St Mary’s and the Western Eye – have a long track record in research and education, influencing clinical practice nationally and worldwide. We also have a growing number of community services and provide private healthcare in dedicated facilities on all of our sites.

Charing Cross Hospital – providing a range of acute and specialist care, including cancer care; it also hosts the hyper acute stroke unit for the region and is a growing hub for integrated care in partnership with local GPs and community providers. Charing Cross has a 24/7 A&E department.

Hammersmith Hospital – a specialist hospital renowned for its strong research connections. It offers a range of services, including renal, haematology, cancer and cardiology care, and provides the regional specialist heart attack centre. As well as being a major base for Imperial College, the Acton site also hosts the clinical sciences centre of the Medical Research Council.

Queen Charlotte’s & Chelsea Hospital – a maternity, women’s and neonatal care hospital, also with strong research links. It has a midwife-led birth centre as well as specialist services for complicated pregnancies, foetal and neonatal care.

St Mary’s Hospital – the major acute hospital for north west London as well as a maternity centre with consultant and midwife-led services. The hospital provides care across a wide range of specialties and runs one of four major trauma centres in London in addition to its 24/7 A&E department.

Western Eye Hospital – a specialist eye hospital with a 24/7 A&E department.


The Trust delivers excellent clinical outcomes for our patients. Our mortality rates remain consistently low based on two indicators, HSMR (Hospital Standardised Mortality Ratio) and SHMI (Summary Hospital-level Mortality Indicator). Both of these show our Trust being amongst the five lowest risk acute Trusts in the country throughout 2017/18.

Research, education and innovation

With our partners, Imperial College London, The Royal Marsden NHS Foundation Trust and Royal Brompton & Harefield NHS Foundation Trust, we form Imperial College Academic Health Science Centre. This is one of 11 academic health science centres in the UK, working to ensure the rapid translation of research for better patient care and excellence in education.

As well as being part of Imperial College Academic Health Science Centre, the Trust, with Imperial College, hosts one of 20 National Institute for Health Research (NIHR) biomedical research centres (BRCs). This designation is given to the most outstanding NHS and university research partnerships in the country, leaders in scientific translation, and early adopters of new insights in technologies, techniques and treatments for improving health.
The NIHR Imperial BRC currently supports over 650 active research projects across 29 different disease areas.

We also lead one of NHS England’s 13 genomic medicine centres – the West London Genomic Medicine Centre – with our partners Chelsea and Westminster Hospital NHS Foundation Trust, Royal Brompton & Harefield NHS Foundation Trust and The Royal Marsden NHS Foundation Trust, helping to lead innovation in genomics.

The Trust is also part of the NIHR Health Informatics Collaborative (NIHR HIC) together with Oxford University Hospitals, Cambridge University Hospitals, University College London Hospitals and Guy’s and St Thomas’ NHS foundation trusts. This collaboration enables NHS clinical data to be linked and shared to allow new insights into care and treatment through research.

In 2017, we were recognised as a leader in the adoption of digital technologies to improve patient care by being selected by NHS England as one of 16 global exemplars of acute care. With our partner, Chelsea and Westminster Hospital NHS Foundation Trust, we received funding and support to drive the use of digital technology to innovate for better patient care and to create products and approaches that can be used by other organisations.

We are a major provider of education and training for doctors, nurses, midwives and allied health professionals including therapists, pharmacists, radiographers and healthcare scientists. In 2017/18, 900 Imperial College London medical undergraduates trained with us. We had over 450 student nurses and midwives in training in the year, many of whom gained their first job or qualification with us.

As lead partner for the West London Genomics Medicine Centre, we continued to expand the number of patients with rare diseases, and their families, as well as patients with common cancers, who have consented to have their genetic make-up sequenced as part of the national 100,000 genomes project. By the end of March 2018, the West London Genomics Medicine Centre had recruited nearly 1,220 cancer patients and 800 patients with a rare disease, plus their families.

Chief Executive: Professor Timothy Orchard

© 2019 — The Shelford Group

Keep up to date

Follow The Shelford Group on Twitter and our RSS Feed.

If you would like more information about the Shelford Group or to get in touch, please click here